RUNX1 and myocardial infarction: In this study, we identified the cardioprotective effect of dihydrolycorine against adverse cardiac remodeling after MI and found that Runx1 is a critical regulator of myocardial fibrosis in the occurrence and development of adverse cardiac remodeling.